These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 3366561

  • 1. Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier.
    Plehwe WE, McRobbie DW, Lerski RA, Kohner EM.
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):663-70. PubMed ID: 3366561
    [Abstract] [Full Text] [Related]

  • 2. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.
    Berkowitz BA, Sato Y, Wilson CA, de Juan E.
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389
    [Abstract] [Full Text] [Related]

  • 3. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI.
    Berkowitz BA, Tofts PS, Sen HA, Ando N, de Juan E.
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3500-6. PubMed ID: 1464496
    [Abstract] [Full Text] [Related]

  • 4. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis.
    Metrikin DC, Wilson CA, Berkowitz BA, Lam MK, Wood GK, Peshock RM.
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1361-70. PubMed ID: 7775114
    [Abstract] [Full Text] [Related]

  • 5. [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].
    Hashimoto K, Yamagata S, Minamikawa J, Watanabe Y, Kanesiro M, Kikuchi H.
    No To Shinkei; 1988 May; 40(5):461-6. PubMed ID: 3415864
    [Abstract] [Full Text] [Related]

  • 6. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
    Hayakawa K, Yamashita K, Mitsumori M, Nakano Y.
    Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
    [Abstract] [Full Text] [Related]

  • 7. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H, Robinson MR, Lizak MJ, Tansey G, Lutz RJ, Yuan P, Wang NS, Csaky KG.
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [Abstract] [Full Text] [Related]

  • 8. In vivo imaging of breakdown of the inner and outer blood-retinal barriers.
    Sen HA, Berkowitz BA, Ando N, de Juan E.
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3507-12. PubMed ID: 1464497
    [Abstract] [Full Text] [Related]

  • 9. MR molecular imaging of early endothelial activation in focal ischemia.
    Barber PA, Foniok T, Kirk D, Buchan AM, Laurent S, Boutry S, Muller RN, Hoyte L, Tomanek B, Tuor UI.
    Ann Neurol; 2004 Jul; 56(1):116-20. PubMed ID: 15236408
    [Abstract] [Full Text] [Related]

  • 10. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging.
    Johnston DL, Liu P, Lauffer RB, Newell JB, Wedeen VJ, Rosen BR, Brady TJ, Okada RD.
    J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546
    [Abstract] [Full Text] [Related]

  • 11. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC.
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits.
    Zhou Z, Guo J, Yu H, Zhu B, Liu C, Jiang X, Zhang M, Chen J.
    J Magn Reson Imaging; 2005 Sep; 22(3):361-7. PubMed ID: 16106365
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G, Frenzel T, Schmitt-Willich H.
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [Abstract] [Full Text] [Related]

  • 14. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P, Montanari N, De Santis M, Pollastri C.
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [Abstract] [Full Text] [Related]

  • 15. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N, Yoshizawa T, Nelson KD, Wilson CA.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [Abstract] [Full Text] [Related]

  • 16. Elimination of gadolinium-DTPA by peritoneal dialysis.
    Dörsam J, Knopp MV, Schad L, Piesche S, Carl S, Oesingmann N.
    Nephrol Dial Transplant; 1995 May; 10(7):1228-30. PubMed ID: 7478129
    [Abstract] [Full Text] [Related]

  • 17. [The observation of blood-brain barrier of organic mercury poisoned rat: a Gd-DTPA enhanced magnetic resonance study].
    Kuwabara T, Yuasa T, Hidaka K, Igarashi H, Kaneko K, Miyatake T.
    No To Shinkei; 1989 Jul; 41(7):681-5. PubMed ID: 2818908
    [Abstract] [Full Text] [Related]

  • 18. Value and limitation of gadolinium-DTPA contrast enhancement in the early detection of acute canine myocardial infarction.
    Nishimura T, Yamada Y, Kozuka T, Nakatani T, Noda H, Takano H.
    Am J Physiol Imaging; 1987 Jul; 2(4):181-5. PubMed ID: 3451771
    [Abstract] [Full Text] [Related]

  • 19. 3D MRI of the cervical spine: low flip angle FISP vs. Gd-DTPA TurboFLASH in degenerative disk disease.
    Ross JS, Ruggieri PM, Glicklich M, Obuchowski N, Dillinger J, Masaryk TJ, Qu Y, Modic MT.
    J Comput Assist Tomogr; 1993 Jul; 17(1):26-33. PubMed ID: 8419435
    [Abstract] [Full Text] [Related]

  • 20. Contrast-enhancing properties of Gd-DTPA at 2.0 Tesla.
    Schmiedl U, Moseley MM, Ogan MD, Chew WM, Brasch RC.
    Radiat Med; 1987 Jul; 5(1):1-5. PubMed ID: 3628851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.